AVITA Medical Reiterates Raised Revenue Guidance Ahead of Investor Webinar
AVH: $4.89 +7.47% · MC: $778M
AVITA Medical’s investor presentation reiterates its 2026 revenue guidance of US$92 million to US$94 million, raised last week from US$86 million to US$89 million. The company continues to expect cash flow breakeven in the fourth quarter. Third-quarter revenue rose 53% from a year earlier to US$26 million, while the net loss more than halved to US$6 million. Chief executive Cary Vance and chief financial officer David O’Toole will discuss the results at an investor webinar on Thursday, Australian time, followed by a question-and-answer session.

Comments